These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11985523)

  • 21. Function of soluble CD14 in serum from patients with septic shock.
    Landmann R; Reber AM; Sansano S; Zimmerli W
    J Infect Dis; 1996 Mar; 173(3):661-8. PubMed ID: 8627030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Nakano H; Hirata I
    Dig Dis Sci; 2009 Jun; 54(6):1247-52. PubMed ID: 18958622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of CD14 shedding from human monocytes. Evidence for the competition of soluble CD14 (sCD14) with CD14 receptors for lipopolysaccharide (LPS) binding.
    Rokita E; Menzel EJ
    APMIS; 1997 Jul; 105(7):510-8. PubMed ID: 9269297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CD14 promoter polymorphisms and soluble CD14 levels in mite allergen sensitization of children in Taiwan.
    Tan CY; Chen YL; Wu LS; Liu CF; Chang WT; Wang JY
    J Hum Genet; 2006; 51(1):59-67. PubMed ID: 16292464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction.
    Hubacek JA; Rothe G; Pit'ha J; Skodová Z; Stanĕk V; Poledne R; Schmitz G
    Circulation; 1999 Jun; 99(25):3218-20. PubMed ID: 10385492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction.
    Hashad IM; Hossni NM; Abdel Rahman MF; Shehata M; Shaban G; Gad MZ
    Curr Pharm Biotechnol; 2018; 19(4):336-342. PubMed ID: 29874995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for links between endotoxin exposure and pregnancy loss: CD14 polymorphism in idiopathic recurrent miscarriage.
    Karhukorpi J; Laitinen T; Karttunen R
    Am J Reprod Immunol; 2003 Oct; 50(4):346-50. PubMed ID: 14672339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer.
    Suleymanov Z
    Turk J Gastroenterol; 2003 Sep; 14(3):168-72. PubMed ID: 14655059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Cd14 as a genetic modifier of experimental inflammatory bowel disease (IBD) in mice.
    de Buhr MF; Hedrich HJ; Westendorf AM; Obermeier F; Hofmann C; Zschemisch NH; Buer J; Bumann D; Goyert SM; Bleich A
    Inflamm Bowel Dis; 2009 Dec; 15(12):1824-36. PubMed ID: 19637338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Distribution and clinical significance of CD14 promoter-159C/T polymorphism in patients with extensive burn].
    Dong N; Yao YM; Yu Y; Cao YJ; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):115-8. PubMed ID: 19799036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host TNF-alpha-1031 and -863 promoter single nucleotide polymorphisms determine the risk of benign ulceration after H. pylori infection.
    Lu CC; Sheu BS; Chen TW; Yang HB; Hung KH; Kao AW; Chuang CH; Wu JJ
    Am J Gastroenterol; 2005 Jun; 100(6):1274-82. PubMed ID: 15929757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.
    Shimada K; Miyauchi K; Mokuno H; Watanabe Y; Iwama Y; Shigekiyo M; Matsumoto M; Okazaki S; Tanimoto K; Kurata T; Sato H; Daida H
    Int J Cardiol; 2004 Mar; 94(1):87-92. PubMed ID: 14996480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status.
    Chang MC; Chang YT; Wei SC; Kuo CH; Liang PC; Wong JM
    Pancreas; 2009 May; 38(4):442-6. PubMed ID: 19276869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS.
    Nockher WA; Scherberich JE
    Kidney Int; 1995 Nov; 48(5):1469-76. PubMed ID: 8544403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels.
    Heesen M; Blömeke B; Schlüter B; Heussen N; Rossaint R; Kunz D
    Intensive Care Med; 2001 Nov; 27(11):1770-5. PubMed ID: 11810121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP.
    de Aguiar BB; Girardi I; Paskulin DD; de Franca E; Dornelles C; Dias FS; Bonorino C; Alho CS
    Immunol Invest; 2008; 37(8):752-69. PubMed ID: 18991094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Helicobacter pylori and interleukin 6 -174 gene polymorphism in dyslipidemia: a case-control study.
    Pohjanen VM; Koivurova OP; Niemelä SE; Karttunen RA; Karttunen TJ
    BMJ Open; 2016 Jan; 6(1):e009987. PubMed ID: 26781506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of interleukin-18 promoter polymorphisms and serum levels with duodenal ulcer, and their correlations with bacterial CagA and VacA virulence factors.
    Rezaeifar A; Eskandari-Nasab E; Moghadampour M; Kharazi-Nejad E; Hasani SS; Asadi-Saghandi A; Hadadi-Fishani M; Sepanjnia A; Sadeghi-Kalani B
    Scand J Infect Dis; 2013 Aug; 45(8):584-92. PubMed ID: 23746337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.
    Yaegashi Y; Shirakawa K; Sato N; Suzuki Y; Kojika M; Imai S; Takahashi G; Miyata M; Furusako S; Endo S
    J Infect Chemother; 2005 Oct; 11(5):234-8. PubMed ID: 16258819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.